Skip to content

Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Undergoing Symptomatic Treatment With Lyrica

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00541476
Enrollment
746
Registered
2007-10-10
Start date
2007-06-30
Completion date
2007-12-31
Last updated
2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuralgia

Brief summary

The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.

Interventions

None listed

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of peripheral or central neuropathic pain

Exclusion criteria

* None. Patients recruited by physician decision. Patient's personal data are not collected.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026